Hinova Pharmaceuticals Inc. (SHA:688302)

Hinova Pharmaceuticals Revenue

Hinova Pharmaceuticals had revenue of 28.95M CNY in the quarter ending June 30, 2026, with 119.83% growth. This brings the company's revenue in the last twelve months to 62.27M, up 363.89% year-over-year. In the year 2025, Hinova Pharmaceuticals had annual revenue of 20.47M with 5,480.12% growth.

• Revenue (ttm): 62.27M
• Revenue Growth: +363.89%
• P/S Ratio: 53.50
• Revenue / Employee: 237.68K
• Employees: 262
• Market Cap: 3.33B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	20.47M	20.10M	5,480.12%
Dec 31, 2024	366.84K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	1.65M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 22, 2026

Data Sources Report a data error